Nora-BE
Name: Nora-BE
Nora-BE Drug Class
Nora-BE is part of the drug class:
- If your symptoms or health problems do not get better or if they become worse, call your doctor.
- Do not share your drugs with others and do not take anyone else's drugs.
- Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.
- Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.
- Some drugs may have another patient information leaflet. Check with your pharmacist. If you have any questions about Nora-BE (norethindrone tablets (contraceptive)), please talk with your doctor, nurse, pharmacist, or other health care provider.
- If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.
This information should not be used to decide whether or not to take this medicine or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about Nora-BE. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using Nora-BE.
Review Date: October 4, 2017
Overdosage
There have been no reports of serious ill effects from overdosage, including ingestion by children.
Principal display panel
Nora-BE®
(Norethindrone 0.35 mg Tablets USP)
52544-629-28
Carton x 6 Tablet Dispensers, 28 Tablets Each
NORA BE
norethindrone tablet |
| Product Information | | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:52544-629 | | Route of Administration | ORAL | DEA Schedule | | |
| Active Ingredient/Active Moiety | | Ingredient Name | Basis of Strength | Strength | | NORETHINDRONE (NORETHINDRONE) | NORETHINDRONE | 0.35 mg | |
| Inactive Ingredients | | Ingredient Name | Strength | | LACTOSE | | | MAGNESIUM STEARATE | | | POVIDONE | | | STARCH, CORN | | |
| Product Characteristics | | Color | WHITE | Score | no score | | Shape | ROUND | Size | 6mm | | Flavor | | Imprint Code | Watson;629 | | Contains | | |
| Packaging | | # | Item Code | Package Description | | 1 | NDC:52544-629-28 | 6 PACKAGE (6 PACKAGE) in 1 CARTON | | 1 | | 28 TABLET (28 TABLET) in 1 PACKAGE | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | NDA AUTHORIZED GENERIC | NDA017060 | 05/12/2005 | | |
| Labeler - Watson Pharma, Inc. (966714656) |
| Establishment |
| Name | Address | ID/FEI | Operations |
| Watson Laboratories, Inc. | | 840054118 | ANALYSIS(52544-629), MANUFACTURE(52544-629) |
Revised: 06/2012 Watson Pharma, Inc.
